ENOV (Enovis) Net Issuance of Preferred Stock: $0 Mil (TTM As of Mar. 2026)


ENOV Enovis Corp ENOV
61 GF Score
Price $21.40
GF Value $49.60
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Enovis Net Issuance of Preferred Stock?

Enovis ENOV +1.18% 61 Net Issuance of Preferred Stock is $0 Mil as of Mar. 2026. GuruFocus rates ENOV with a GF Score™ of 61/100 and a GF Value™ of $49.60 (Possible Value Trap). The stock has 6 warning signs investors should review.

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Enovis's net issuance of preferred for the three months ended in Mar. 2026 was $0 Mil. The number is 0, which means that Enovis has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Enovis's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Enovis Net Issuance of Preferred Stock Related Terms

Enovis Net Issuance of Preferred Stock Historical Data

* Premium members only.

The historical data trend for Enovis's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enovis Net Issuance of Preferred Stock Chart

Enovis Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enovis Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ENOV
61GF Score
Enovis Corp ENOV
Net Issuance of Preferred Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enovis Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Issuance of Preferred Stock of $0 Mil mean?
Enovis (ENOV) has a Net Issuance of Preferred Stock of $0 Mil as of Mar. 2026. Net Issuance of Preferred Stock represents the difference between preferred stock issued and preferred stock repurchased. View historical data for Enovis.
Is Enovis' Net Issuance of Preferred Stock too high?
Enovis' current Net Issuance of Preferred Stock is $0 Mil. Overall, Enovis has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Enovis' Net Issuance of Preferred Stock compare to IART and AHCO?
Enovis' Net Issuance of Preferred Stock of $0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Issuance of Preferred Stock for a Medical Devices & Instruments company?
A good Net Issuance of Preferred Stock depends on the Medical Devices & Instruments industry context. However, Net Issuance of Preferred Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Issuance of Preferred Stock mean?
A high Net Issuance of Preferred Stock can signal that a stock is expensive relative to its fundamentals. Net Issuance of Preferred Stock represents the difference between preferred stock issued and preferred stock repurchased. View historical data for Enovis. Enovis's current Net Issuance of Preferred Stock is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enovis stock overvalued right now?
Based on GuruFocus' analysis, Enovis (ENOV) is currently considered Possible Value Trap. The stock's GF Value™ is $49.60, compared to a current price of $21.40 — trading 56.9% below its estimated fair value. The current Net Issuance of Preferred Stock is $0 Mil. Enovis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Issuance of Preferred Stock calculated?
Net Issuance of Preferred Stock is calculated from a company's financial statements. For Enovis (ENOV), the current Net Issuance of Preferred Stock is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Enovis (ENOV) Overvalued in 2026?

Based on GuruFocus' analysis, Enovis stock appears to be undervalued. The current stock price of $21.40 is trading 56.9% below its estimated GF Value™ of $49.60. GuruFocus considers Enovis to be Possible Value Trap.

Key valuation signals for ENOV:

  • Net Issuance of Preferred Stock: $0 Mil
  • GF Value™: $49.60 vs. price of $21.40 (56.9% below fair value)
  • GF Score™: 61/100 with 6 warning signs

No single metric tells the full story. See the ENOV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Enovis Business Description

Address 2711 Centerville Road, Suite 400, Wilmington, DE, USA, 19808
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
61GF Score

Get the complete analysis for ENOV

Net Issuance of Preferred Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.40
Price
$49.60
GF Value